Rapamycin used to prevent organ rejection after transplants and in cancer treatment was found to have anti-ageing effect and potential to treat COVID-19 patients.
The University of Nebraska Medical Center and Hemispherx Biopharma are partnering to take on pancreatic cancer, one of the most deadly forms of cancer.